fda warning letters glp-1 compounders september 2025 news Why the Issued 30 to Telehealth Sites Marketing Compounded GLP-1s From Crackdown to Collaboration: FDA

Mazza Acquisition, analysis, or interpretation of data: Angela D

Weight loss on GLP-1 medicines is rarely a straight line

Could a supply shortage be dangerous for people with diabetes who need these drugs

The study showed a reduction between 10% and 20% in lung failure, pneumonia, Alzheimers disease, lung failure, heart failure, and cardiac arrest among people who used GLP-1 drugs

Your cancer treatment remains fully effective

Investors might be better served by taking a less focused approach toward investing in obesity stocks and consider a firm like Roche, where we like the overall portfolio and investors get some exposure to new obesity drug development, Conover says